A Study Of Melanoma Survivorship

Overview

About this study

The purpose of this study is to define define preliminary quality of life inclusive of mental health (QOL-MH) within this new generation of survivors.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Age >= 18-years

  • Stage III-IV melanoma and <= 2 month duration of this diagnosis

  • Able to read English sufficient to complete survey, informed consent

 

Exclusion Criteria:

  • None

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 

Eligibility last updated 07/02/2025. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Shawna Ehlers, Ph.D., L.P., ABPP

Open for enrollment

More information

Publications

Publications are currently not available
.
CLS-20598365

Mayo Clinic Footer